Stock Price
30.39
Daily Change
-2.53%
Yearly
38.14%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Eisai 6,793.00 -67.00 -0.98% -11.51%
Abbott 130.27 1.89 1.47% 20.73%
Aurora Cannabis Inc 7.44 -0.43 -5.46% -46.44%
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
Aerie Pharmaceuticals 10.22 -0.14 -1.35% -19.97%
ANI Pharmaceuticals 39.55 -1.45 -3.54% 34.84%
Aphria Inc 16.55 -0.98 -5.59% 225.79%
Antares Pharma 3.15 -0.11 -3.37% -5.69%
Bristol-Myers Squibb 56.32 0.91 1.64% -9.61%
Cara Therapeutics 12.31 -0.58 -4.50% -18.37%
Corcept Therapeutics 20.91 -0.50 -2.34% -11.21%
Endo International Ordinary Shares 4.99 -0.29 -5.49% -7.25%
GW Pharmaceuticals 218.96 0 0% 108.53%
Horizon Pharma 99.84 -3.89 -3.75% 39.21%
Jazz Pharmaceuticals 120.26 -2.44 -1.99% -20.20%
Lannett 1.78 0.08 4.71% -73.75%
Eli Lilly 245.58 -2.30 -0.93% 65.43%
Marinus Pharmaceuticals 9.31 -1.01 -9.79% -36.12%
Pacira 52.53 -1.22 -2.27% -13.33%
Pfizer 54.27 1.23 2.32% 34.53%
Perrigo 35.79 -0.04 -0.11% -28.23%
Revance Therapeutics 14.60 -0.20 -1.35% -39.97%
Supernus Pharmaceuticals 30.39 -0.79 -2.53% 38.14%
Teva Pharmaceutical Industries 8.05 -0.11 -1.35% -21.69%
United Therapeutics 185.99 -3.30 -1.74% 39.35%
Canopy Growth Corp 12.85 -0.43 -3.24% -64.76%
Xeris Pharmaceuticals Inc 2.04 0.04 2.00% -51.66%

Indexes Price Day Year
NASDAQ 15085 -295.85 -1.92% 21.03%
US2000 2159 -47.02 -2.13% 14.10%

Supernus Pharmaceuticals
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Its diverse neuroscience portfolio includes treatments for epilepsy, migraine, hypomobility in Parkinson’s Disease (PD), cervical dystonia, and chronic sialorrhea. Its commercial portfolio of products includes Trokendi XR (topiramate) and Oxtellar XR (oxcarbazepine) for the treatment of epilepsy. Its APOKYN (apomorphine hydrochloride injection) is a product indicated for the acute, intermittent treatment of hypomobility in patients with advanced parkinson’s disease (PD). Its XADAGO (safinamide) is a product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD. Its MYOBLOC (rimabotulinumtoxinB) is a product indicated for the treatment of cervical dystonia and sialorrhea in adults. Its pipeline of CNS product candidates includes SPN-812, SPN-817, SPN-820, SPN-830 and MYOBLOC.